Key result
Enhanced posttranslational modification signaling restores aged pacemaker beating rates to adult levels in modeling.
A numerical model of a mouse pacemaker cell demonstrates that age-related deterioration in pacemaker function is driven by impaired membrane and intracellular mechanisms, which can be reversed by enhancing posttranslational modification signaling.
Answers are grounded in this paper and cite their sources.
Should not change clinical practice; leaves open whether posttranslational modification signaling can be targeted to restore pacemaker function in aged humans.
Age-related deterioration of pacemaker function has been documented in mammals, including humans. In aged isolated sinoatrial node tissues and cells, reduction in the spontaneous action potential (AP) firing rate was associated with deterioration of intracellular and membrane mechanisms; however, their relative contribution to age-associated deficient pacemaker function is not known. Interestingly, pharmacological interventions that increase posttranslation modification signaling activities can restore the basal and maximal AP firing rate, but the identities of the protein targets responsible for AP firing rate restoration are not known. Here, we developed a numerical model that simulates the function of a single mouse pacemaker cell. In addition to describing membrane and intracellular mechanisms, the model includes descriptions of autonomic receptor activation pathways and posttranslation modification signaling cascades. The numerical model shows that age-related deterioration of pacemaker function is related to impaired intracellular and membrane mechanisms: HCN4, T-type channels, and phospholamban functions, as well as the node connecting these mechanisms, i.e., intracellular Ca2+ and posttranslation modification signaling. To explain the restored maximal beating rate in response to maximal phosphodiesterase (PDE) inhibition, autonomic receptor stimulation, or infused cyclic adenosine monophosphate (cAMP), the model predicts that phospholamban phosphorylation by protein kinase A (PKA) and HCN4 sensitivity to cAMP are altered in advanced age. Moreover, alteration in PKA and cAMP sensitivity can also explain age-reduced sensitivity to PDE inhibition and autonomic receptor stimulation. Finally, the numerical model suggests two pharmacological approaches and one gene manipulation method to restore the basal beating rate of aged pacemaker cells to that of normal adult cells. In conclusion, our numerical model shows that impaired membrane and intracellular mechanisms and the nodes that couple them can lead to deteriorated pacemaker function. By increasing posttranslation modification signaling, the deteriorated basal and maximal age-associated beating rate can be restored to adult levels.
No takes yet. Share an insight, caveat, or question.
Behar et al. (2017) studied Age-related pacemaker deterioration. Pharmacological interventions (IBMX, Isoproterenol) or gene manipulation (AC1/AC8 overexpression) vs. Untreated aged pacemaker cell model was evaluated on Restoration of basal and maximal action potential (AP) firing rate. Numerical modeling demonstrated that impaired membrane and intracellular mechanisms in aged pacemaker cells can be compensated for, restoring basal and maximal beating rates to adult levels by increasing posttranslational modification signaling.
Synapse has enriched 10 related papers. Consider them for comparative context: